investments-large-investment-17.html
Novo Annual Review 2016
18 / 71
large
investments
in dkk million value at the end of the year
investments
during the year cash proceeds during the year unrealised and realised returns during the year 31,499 2016 2015 27,774 1,205 703 6,482 -2,146 6,577 2,594 portfolio composition
large
investments
in brief 2016
large
investments
covers novo a/s? direct investment efforts in well- established life science
companies
. these
companies
are characterised by their strong market position, attractive growth prospects, and an ambitious innovation agenda.
large
investments
was established as a separate entity in 2013. following an extensive strategic review in 2016, this area was highlighted as one where novo will place significant further
investments
in the years to come. 2 ? medtech 1 ? medical laboratory services 2 ? private majority 3 ? private minority 1 ? bioindustrials 1 ? healthcare it 5 ? pharmaceuticals 5 ? public minority sector allocation by number of
companies
ownership allocation by number of
companies
18 novo a/s 2016
allocation-number-geographical-19.html
